| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Hematology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Continuous renal replacement therapy with oXiris® in hematological malignant septic shock patients: A retrospective study
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Juan Wang, Shu-Run Wei, Tong Ding, Li-Ping Zhang, Zhi-Hua Weng, Ming Cheng, Yang Zhou, Meng Zhang, Fang-Jun Liu, Bei-Bei Yan, Dan-Feng Wang, Ming-Wen Sun and Wei-Xin Cheng |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Hebei Health Science and Education Project |
20200852 |
|
| Corresponding Author |
Wei-Xin Cheng, MD, Doctor, Doctor, Emergency Department, Peking University International Hospital, No. 1 Life Park Road, Life Science Park of Zhong Guancun, Changping District, Beijing 102206, China. 18911652172@163.com |
| Key Words |
Hematologic malignancy; Septic shock; oXiris® hemofilter; Blood purification; Fluid balance |
| Core Tip |
The oXiris® is a high permeability polyacrylonitrile-based membrane with enhanced endotoxic blood adsorption and cytokine removal, it could be used either in continuous veno-venous hemofiltration or continuous veno-venous hemodiafiltration. In this study, the authors explored its effect through shortening resuscitation time as well as a modifier for host response by reducing inflammation mediator. |
| Publish Date |
2023-09-08 09:38 |
| Citation |
Wang J, Wei SR, Ding T, Zhang LP, Weng ZH, Cheng M, Zhou Y, Zhang M, Liu FJ, Yan BB, Wang DF, Sun MW, Cheng WX. Continuous renal replacement therapy with oXiris® in hematological malignant septic shock patients: A retrospective study . World J Clin Cases 2023; 11(26): 6073-6082 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i26/6073.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i26.6073 |
